Skip to Content
Merck
  • EHMT2 inhibitor BIX-01294 induces apoptosis through PMAIP1-USP9X-MCL1 axis in human bladder cancer cells.

EHMT2 inhibitor BIX-01294 induces apoptosis through PMAIP1-USP9X-MCL1 axis in human bladder cancer cells.

Cancer cell international (2015-02-17)
Jing Cui, Wendong Sun, Xuexi Hao, Minli Wei, Xiaonan Su, Yajing Zhang, Ling Su, Xiangguo Liu
ABSTRACT

BIX-01294, an euchromatic histone-lysine N-methyltransferase 2 (EHMT2) inhibitor, has been reported to induce apoptosis in human neuroblastoma cells and inhibit the proliferation of bladder cancer cells. However, the definite mechanism of the apoptosis mediated by BIX-01294 in bladder cancer cells remains unclear. In the present study, we found that BIX-01294 induced caspase-dependent apoptosis in human bladder cancer cells. Moreover, our data show BIX-01294 stimulates endoplasmic reticulum stress (ER stress) and up-regulated expression of PMAIP1 through DDIT3 up-regulation. Furthermore, down-regulation of the deubiquitinase USP9X by BIX-01294 results in downstream reduction of MCL1 expression, leading to apoptosis eventually. Thus, our findings demonstrate PMAIP1-USP9X-MCL1 axis may contribute to BIX-01294-induced apoptosis in human bladder cancer cells.

MATERIALS
Product Number
Brand
Product Description

Roche
X-tremeGENE HP DNA Transfection Reagent, High-performance polymer reagent for transfecting many cell lines
Sigma-Aldrich
Anti-Noxa Mouse mAb (114C307), liquid, clone 114C307, Calbiochem®